Mayo Clinic at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
Mayo Clinic brings 8 presentations to ASH 2026 in New Orleans. Its program centres on multiple myeloma and related plasma cell disorders, from AL amyloidosis and BCMA-targeted bispecifics to mouse models and real-world myeloma data. It also covers rarer problems such as methemoglobinemia testing, VEXAS and monoclonal gammopathy linked to blood clots.
| Organization | ASH 2026 Attendance |
|---|---|
Mayo Clinic Rochester, MN | |
Non-profit academic medical center with main campuses in Minnesota, Arizona and Florida, providing patient care, research and education. | Symposium Fri Dec 11 11:00am–2:00pm Actionable Approaches to AL Amyloidosis Care: Diagnosing Earlier, Treating Smarter, Managing Together Diagnosing light-chain amyloidosis earlier, personalizing treatment including fibril-targeting drugs, supporting patients, and improving team workflows. Symposium Fri Dec 11 7:00am–10:00am Anti-BCMA Bispecific Antibodies in Multiple Myeloma: From Biology to Real-World Implementation Bispecific antibodies targeting B-cell maturation antigen in myeloma, from mechanism and resistance to trial data, outpatient dosing, and infection prevention. Symposium Fri Dec 11 11:00am–2:00pm Transforming Care for Newly-Diagnosed Multiple Myeloma: Integrating Evidence-Based Innovation into Community Practice Newly diagnosed multiple myeloma care in community clinics, using frailty assessment, dose adjustment to protect quality of life, and new drug formulations. Talk Running on Wheels: How Mouse Models Inform the Study of Plasma Cell Biology Immune-competent mouse models of multiple myeloma that mimic its interplay with bone marrow, used to test new immune and cell therapies before trials. Talk Clonal Dominance in VEXAS An adult-onset inflammatory blood disorder caused by mutation of one protein-tagging enzyme, and how extra mutations shape inflammation and treatment. Session Don't Miss It! Methemoglobinemia: Inherited and Acquired How to evaluate unexplained cyanosis, recognize inherited or acquired methemoglobinemia with lab tests, and manage it without costly unnecessary workups. Talk Laboratory Testing in Methemoglobinemia Lab diagnosis of methemoglobinemia and sulfhemoglobinemia, where altered hemoglobin carries oxygen poorly, and test pitfalls in inherited versus acquired cases. Talk Older Adults Take the Lead: Revolutionizing B-cell ALL Treatment with Chemo-Sparing Approaches Chemotherapy-light care of older adults with B-cell acute lymphoblastic leukemia, using fitness and residual disease to sequence immunotherapies and transplant. Talk Session Treating Fairly Rounds Lunch How hematologists and fellows can influence healthcare reform on research funding, Medicaid, and hospital budgets, and how policy shapes health inequities. |
Instantly find 20 buyers from Mayo Clinic
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction